Click for best price
Donohue Syndrome Treatment Market Size, Share 2024
The global Donohue Syndrome Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
IGF-1 Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Donohue Syndrome Treatment include Medtronic plc, Hoffmann-La Roche Ltd, Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Sooil Development, JingasuDelfu Co., Ltd., Becton Dickinson and Company and Braun Melsungen AG, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Donohue Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Donohue Syndrome Treatment. This report contains market size and forecasts of Donohue Syndrome Treatment in global, including the following market information:
Global Donohue Syndrome Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Donohue Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Donohue Syndrome Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Donohue Syndrome Treatment Market Segment Percentages, by Type, 2023 (%)
IGF-1 Therapy
Insulin Pump Therapy
Global Donohue Syndrome Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Donohue Syndrome Treatment Market Segment Percentages, by Application, 2023 (%)
Hospitals
Clinics
Others
Global Donohue Syndrome Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Donohue Syndrome Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Donohue Syndrome Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Donohue Syndrome Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic plc
Hoffmann-La Roche Ltd
Tandem Diabetic Care, Inc.
Insulet Corporation
Ypsomed
Sooil Development
JingasuDelfu Co., Ltd.
Becton Dickinson and Company
Braun Melsungen AG
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Donohue Syndrome Treatment, market overview.
Chapter 2: Global Donohue Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Donohue Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Donohue Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Donohue Syndrome Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Donohue Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Donohue Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Donohue Syndrome Treatment Overall Market Size
2.1 Global Donohue Syndrome Treatment Market Size: 2023 VS 2030
2.2 Global Donohue Syndrome Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Donohue Syndrome Treatment Players in Global Market
3.2 Top Global Donohue Syndrome Treatment Companies Ranked by Revenue
3.3 Global Donohue Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Donohue Syndrome Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Donohue Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Donohue Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Donohue Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Donohue Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Donohue Syndrome Treatment Market Size Markets, 2023 & 2030
4.1.2 IGF-1 Therapy
4.1.3 Insulin Pump Therapy
4.2 By Type - Global Donohue Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Donohue Syndrome Treatment Revenue, 2019-2024
4.2.2 By Type - Global Donohue Syndrome Treatment Revenue, 2025-2030
4.2.3 By Type - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Donohue Syndrome Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Donohue Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Donohue Syndrome Treatment Revenue, 2019-2024
5.2.2 By Application - Global Donohue Syndrome Treatment Revenue, 2025-2030
5.2.3 By Application - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Donohue Syndrome Treatment Market Size, 2023 & 2030
6.2 By Region - Global Donohue Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Donohue Syndrome Treatment Revenue, 2019-2024
6.2.2 By Region - Global Donohue Syndrome Treatment Revenue, 2025-2030
6.2.3 By Region - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Donohue Syndrome Treatment Revenue, 2019-2030
6.3.2 US Donohue Syndrome Treatment Market Size, 2019-2030
6.3.3 Canada Donohue Syndrome Treatment Market Size, 2019-2030
6.3.4 Mexico Donohue Syndrome Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Donohue Syndrome Treatment Revenue, 2019-2030
6.4.2 Germany Donohue Syndrome Treatment Market Size, 2019-2030
6.4.3 France Donohue Syndrome Treatment Market Size, 2019-2030
6.4.4 U.K. Donohue Syndrome Treatment Market Size, 2019-2030
6.4.5 Italy Donohue Syndrome Treatment Market Size, 2019-2030
6.4.6 Russia Donohue Syndrome Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Donohue Syndrome Treatment Market Size, 2019-2030
6.4.8 Benelux Donohue Syndrome Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Donohue Syndrome Treatment Revenue, 2019-2030
6.5.2 China Donohue Syndrome Treatment Market Size, 2019-2030
6.5.3 Japan Donohue Syndrome Treatment Market Size, 2019-2030
6.5.4 South Korea Donohue Syndrome Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Donohue Syndrome Treatment Market Size, 2019-2030
6.5.6 India Donohue Syndrome Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Donohue Syndrome Treatment Revenue, 2019-2030
6.6.2 Brazil Donohue Syndrome Treatment Market Size, 2019-2030
6.6.3 Argentina Donohue Syndrome Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Donohue Syndrome Treatment Revenue, 2019-2030
6.7.2 Turkey Donohue Syndrome Treatment Market Size, 2019-2030
6.7.3 Israel Donohue Syndrome Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Donohue Syndrome Treatment Market Size, 2019-2030
6.7.5 UAE Donohue Syndrome Treatment Market Size, 2019-2030
7 Donohue Syndrome Treatment Companies Profiles
7.1 Medtronic plc
7.1.1 Medtronic plc Company Summary
7.1.2 Medtronic plc Business Overview
7.1.3 Medtronic plc Donohue Syndrome Treatment Major Product Offerings
7.1.4 Medtronic plc Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.1.5 Medtronic plc Key News & Latest Developments
7.2 Hoffmann-La Roche Ltd
7.2.1 Hoffmann-La Roche Ltd Company Summary
7.2.2 Hoffmann-La Roche Ltd Business Overview
7.2.3 Hoffmann-La Roche Ltd Donohue Syndrome Treatment Major Product Offerings
7.2.4 Hoffmann-La Roche Ltd Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.2.5 Hoffmann-La Roche Ltd Key News & Latest Developments
7.3 Tandem Diabetic Care, Inc.
7.3.1 Tandem Diabetic Care, Inc. Company Summary
7.3.2 Tandem Diabetic Care, Inc. Business Overview
7.3.3 Tandem Diabetic Care, Inc. Donohue Syndrome Treatment Major Product Offerings
7.3.4 Tandem Diabetic Care, Inc. Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.3.5 Tandem Diabetic Care, Inc. Key News & Latest Developments
7.4 Insulet Corporation
7.4.1 Insulet Corporation Company Summary
7.4.2 Insulet Corporation Business Overview
7.4.3 Insulet Corporation Donohue Syndrome Treatment Major Product Offerings
7.4.4 Insulet Corporation Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.4.5 Insulet Corporation Key News & Latest Developments
7.5 Ypsomed
7.5.1 Ypsomed Company Summary
7.5.2 Ypsomed Business Overview
7.5.3 Ypsomed Donohue Syndrome Treatment Major Product Offerings
7.5.4 Ypsomed Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.5.5 Ypsomed Key News & Latest Developments
7.6 Sooil Development
7.6.1 Sooil Development Company Summary
7.6.2 Sooil Development Business Overview
7.6.3 Sooil Development Donohue Syndrome Treatment Major Product Offerings
7.6.4 Sooil Development Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.6.5 Sooil Development Key News & Latest Developments
7.7 JingasuDelfu Co., Ltd.
7.7.1 JingasuDelfu Co., Ltd. Company Summary
7.7.2 JingasuDelfu Co., Ltd. Business Overview
7.7.3 JingasuDelfu Co., Ltd. Donohue Syndrome Treatment Major Product Offerings
7.7.4 JingasuDelfu Co., Ltd. Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.7.5 JingasuDelfu Co., Ltd. Key News & Latest Developments
7.8 Becton Dickinson and Company
7.8.1 Becton Dickinson and Company Company Summary
7.8.2 Becton Dickinson and Company Business Overview
7.8.3 Becton Dickinson and Company Donohue Syndrome Treatment Major Product Offerings
7.8.4 Becton Dickinson and Company Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.8.5 Becton Dickinson and Company Key News & Latest Developments
7.9 Braun Melsungen AG
7.9.1 Braun Melsungen AG Company Summary
7.9.2 Braun Melsungen AG Business Overview
7.9.3 Braun Melsungen AG Donohue Syndrome Treatment Major Product Offerings
7.9.4 Braun Melsungen AG Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.9.5 Braun Melsungen AG Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Donohue Syndrome Treatment Major Product Offerings
7.10.4 Sanofi Donohue Syndrome Treatment Revenue in Global Market (2019-2024)
7.10.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Donohue Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Donohue Syndrome Treatment Market Drivers in Global Market
Table 3. Donohue Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Donohue Syndrome Treatment in Global Market
Table 5. Top Donohue Syndrome Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Donohue Syndrome Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Donohue Syndrome Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Donohue Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Donohue Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Donohue Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Donohue Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Donohue Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Donohue Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Donohue Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Donohue Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Donohue Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Donohue Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Donohue Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Donohue Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Donohue Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Donohue Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Donohue Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Donohue Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Donohue Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 30. Medtronic plc Company Summary
Table 31. Medtronic plc Donohue Syndrome Treatment Product Offerings
Table 32. Medtronic plc Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. Medtronic plc Key News & Latest Developments
Table 34. Hoffmann-La Roche Ltd Company Summary
Table 35. Hoffmann-La Roche Ltd Donohue Syndrome Treatment Product Offerings
Table 36. Hoffmann-La Roche Ltd Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 38. Tandem Diabetic Care, Inc. Company Summary
Table 39. Tandem Diabetic Care, Inc. Donohue Syndrome Treatment Product Offerings
Table 40. Tandem Diabetic Care, Inc. Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. Tandem Diabetic Care, Inc. Key News & Latest Developments
Table 42. Insulet Corporation Company Summary
Table 43. Insulet Corporation Donohue Syndrome Treatment Product Offerings
Table 44. Insulet Corporation Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Insulet Corporation Key News & Latest Developments
Table 46. Ypsomed Company Summary
Table 47. Ypsomed Donohue Syndrome Treatment Product Offerings
Table 48. Ypsomed Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Ypsomed Key News & Latest Developments
Table 50. Sooil Development Company Summary
Table 51. Sooil Development Donohue Syndrome Treatment Product Offerings
Table 52. Sooil Development Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Sooil Development Key News & Latest Developments
Table 54. JingasuDelfu Co., Ltd. Company Summary
Table 55. JingasuDelfu Co., Ltd. Donohue Syndrome Treatment Product Offerings
Table 56. JingasuDelfu Co., Ltd. Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. JingasuDelfu Co., Ltd. Key News & Latest Developments
Table 58. Becton Dickinson and Company Company Summary
Table 59. Becton Dickinson and Company Donohue Syndrome Treatment Product Offerings
Table 60. Becton Dickinson and Company Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Becton Dickinson and Company Key News & Latest Developments
Table 62. Braun Melsungen AG Company Summary
Table 63. Braun Melsungen AG Donohue Syndrome Treatment Product Offerings
Table 64. Braun Melsungen AG Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Braun Melsungen AG Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Donohue Syndrome Treatment Product Offerings
Table 68. Sanofi Donohue Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Donohue Syndrome Treatment Segment by Type in 2023
Figure 2. Donohue Syndrome Treatment Segment by Application in 2023
Figure 3. Global Donohue Syndrome Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Donohue Syndrome Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Donohue Syndrome Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Donohue Syndrome Treatment Revenue in 2023
Figure 8. By Type - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Donohue Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Donohue Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 16. US Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 28. China Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Donohue Syndrome Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Donohue Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. Medtronic plc Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Hoffmann-La Roche Ltd Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Tandem Diabetic Care, Inc. Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Insulet Corporation Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Ypsomed Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Sooil Development Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. JingasuDelfu Co., Ltd. Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Becton Dickinson and Company Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Braun Melsungen AG Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Sanofi Donohue Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
